Your browser doesn't support javascript.
loading
The human melanoma proteome atlas-Defining the molecular pathology.
Betancourt, Lazaro Hiram; Gil, Jeovanis; Kim, Yonghyo; Doma, Viktória; Çakir, Ugur; Sanchez, Aniel; Murillo, Jimmy Rodriguez; Kuras, Magdalena; Parada, Indira Pla; Sugihara, Yutaka; Appelqvist, Roger; Wieslander, Elisabet; Welinder, Charlotte; Velasquez, Erika; de Almeida, Natália Pinto; Woldmar, Nicole; Marko-Varga, Matilda; Pawlowski, Krzysztof; Eriksson, Jonatan; Szeitz, Beáta; Baldetorp, Bo; Ingvar, Christian; Olsson, Håkan; Lundgren, Lotta; Lindberg, Henrik; Oskolas, Henriett; Lee, Boram; Berge, Ethan; Sjögren, Marie; Eriksson, Carina; Kim, Dasol; Kwon, Ho Jeong; Knudsen, Beatrice; Rezeli, Melinda; Hong, Runyu; Horvatovich, Peter; Miliotis, Tasso; Nishimura, Toshihide; Kato, Harubumi; Steinfelder, Erik; Oppermann, Madalina; Miller, Ken; Florindi, Francesco; Zhou, Qimin; Domont, Gilberto B; Pizzatti, Luciana; Nogueira, Fábio C S; Horvath, Peter; Szadai, Leticia; Tímár, József.
Affiliation
  • Betancourt LH; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Gil J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Kim Y; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Doma V; Department of Pathology, Semmelweis University, Hungary.
  • Çakir U; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Sanchez A; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Murillo JR; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Kuras M; Department of Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Parada IP; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Sugihara Y; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Appelqvist R; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Wieslander E; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Welinder C; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Velasquez E; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • de Almeida NP; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Woldmar N; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Marko-Varga M; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Pawlowski K; Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Eriksson J; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Szeitz B; Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Baldetorp B; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Ingvar C; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Olsson H; Department of Molecular Biology, University of Texas Southwestern Medical Center, Texas, USA.
  • Lundgren L; Department of Biochemistry and Microbiology, Warsaw University of Life Sciences, Warszawa, Poland.
  • Lindberg H; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Oskolas H; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Lee B; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Berge E; SUS University Hospital Lund, Lund, Sweden.
  • Sjögren M; Department of Surgery, Clinical Sciences, Lund University, SUS, Lund, Sweden.
  • Eriksson C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Kim D; SUS University Hospital Lund, Lund, Sweden.
  • Kwon HJ; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Knudsen B; SUS University Hospital Lund, Lund, Sweden.
  • Rezeli M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Hong R; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Horvatovich P; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Miliotis T; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Nishimura T; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Kato H; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Steinfelder E; Chemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Oppermann M; Chemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Miller K; Department of Pathology, University of Utah, Salt Lake City, USA.
  • Florindi F; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Zhou Q; Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Grossman School of Medicine, New York, USA.
  • Domont GB; Department of Analytical Biochemistry, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.
  • Pizzatti L; Translational Science and Experimental Medicine, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Nogueira FCS; Department of Oncology, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Horvath P; Department of Surgery, Tokyo Medical University, Tokyo, Japan.
  • Szadai L; ThermoFisher Scientific, HQ, San Jose, California, USA.
  • Tímár J; ThermoFisher Scientific, HQ, San Jose, California, USA.
Clin Transl Med ; 11(7): e473, 2021 07.
Article de En | MEDLINE | ID: mdl-34323403
ABSTRACT
The MM500 study is an initiative to map the protein levels in malignant melanoma tumor samples, focused on in-depth histopathology coupled to proteome characterization. The protein levels and localization were determined for a broad spectrum of diverse, surgically isolated melanoma tumors originating from multiple body locations. More than 15,500 proteoforms were identified by mass spectrometry, from which chromosomal and subcellular localization was annotated within both primary and metastatic melanoma. The data generated by global proteomic experiments covered 72% of the proteins identified in the recently reported high stringency blueprint of the human proteome. This study contributes to the NIH Cancer Moonshot initiative combining detailed histopathological presentation with the molecular characterization for 505 melanoma tumor samples, localized in 26 organs from 232 patients.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Protéome / Protéomique / Mélanome Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Clin Transl Med Année: 2021 Type de document: Article Pays d'affiliation: Suède

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Protéome / Protéomique / Mélanome Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Clin Transl Med Année: 2021 Type de document: Article Pays d'affiliation: Suède